Valorization Manager Filip Legein represented µFlow Cell at BioFIT/MedFIT 2025 in Strasbourg, a unique event bringing together academics and industry. In the one-to-one meetings, microfluidics was discussed as an enabling technology for biotech and medtech applications, and MicroFlow Cell's key areas of expertise were presented. The pitches from start-up companies seeking investment and the panel discussions provided a very good view of what is happening in the market.